Health, Wellness, and BeautyPatient Safety Management4HighNurse$ implied
Night-shift nurse struggles to act on abnormal lab results because on-call physicians refuse to handle non-emergent care overnight, leaving proactive patient management undone.
Existing hospital communication and escalation systems lack a structured process for nurses to escalate non-emergent but clinically significant findings overnight without being dismissed.
52
0
Opp. Score
52
Severity
4High
Willingness to Pay
implied
Added
Apr 24, 2026
Workarounds Described
- Nurse manually reviews entire patient chart overnight to catch missed results
- Nurse pages on-call physician and gets dismissed verbally
Implied Software Gaps
- Real-time clinical alerting system for non-critical abnormal results that escalates to both nurse and on-call team with recommended actions
App Concept
NightWatch Escalation
NightWatch Escalation is a HIPAA-compliant platform that enables night-shift nurses to flag and escalate non-emergent clinical concerns with structured clinical decision support, ensuring timely review and documentation without relying on dismissive phone calls.
Key Features
- Structured escalation templates for common overnight concerns like positive cultures, abnormal vitals trends, and medication issues
- Built-in clinical decision support that suggests protocols (e.g., when to consult ID) based on patient data
- Auto-log all escalations to the patient chart for day-shift handoff
- Secure messaging with on-call physicians that includes mandatory response acknowledgment
Target Users: Night-shift nurses and nursing supervisors in acute care hospitals (especially teaching hospitals and community hospitals with limited overnight physician coverage)
Revenue Model: Subscription: $15/mo per nurse + $50/mo per physician user, or hospital-wide license starting at $2,000/mo for 100+ users
Part of App Idea
Patient Safety RadarWant to go deeper?
Sign up to save ideas, run AI analysis, and track opportunities in your personal workspace. Founding members get full access.
Join BetaSolutions (0)
Discussion (0)
No comments yet